3D Bioprinting Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

3D Bioprinting Market

 

Market Analysis

The global 3D bioprinting market is likely to touch USD 1923.02 million at a whopping 24.59% CAGR between 2018-2023, as per the recent Market Research Future (MRFR) report. 3D bioprinting includes various 3D printing techniques to combine biomaterials and cells for producing biomedical parts. It has wide applications, including clinical and research.

Numerous factors are adding to the global 3D bioprinting market growth. These factors, according to the recent Market Research Future report, include growing need for transplantation of organs, rising investment in R&D activities, increasing geriatric population, technological advances to manufacture custom made products, innovations, and developments in 3D bioprinting, and increasing use in cosmetic surgery and drug discovery.

On the flipside, limitations on products that are biomaterial-based coupled with socio-ethical concerns may limit the market growth during the forecast period.

3D Bioprinting Market Segmentation

Based on the segment, the global 3D bioprinting market has been segmented based on material, end user, technology, and application.

By technology, the global 3D bioprinting market has been segmented into inkjet 3D bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and laser-assisted bioprinting. Among these, microextrusion bioprinting will lead the market during the forecast period for its extensive applications in bioprinting.

By material, the global 3D bioprinting market has been segmented into hydrogels, living cells, and extracellular matrices. Among these, living cells will have the largest share in the market during the forecast period.

By applications, the market has been segmented into research and clinical applications. Among these, research applications will dominate the market during the forecast period for its extensive application in 3D cell culture and regenerative medicine.

By end users, the global 3D bioprintingmarket has been segmented into pharmaceutical & biotechnology companies and research organizations & academic institutes. Among these, pharmaceutical & biotechnology companies will hold the largest share in the market during the forecast period.

Get Sample Report: https://www.marketresearchfuture.com/sample_request/869

Regional Analysis

By region, the global 3D bioprinting market has been segmented based on the following regions- the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Among these, the Americas will dominate the 3D bioprinting market over the forecast period and is likely to touch USD 689.91 million by the end of 2023. Factors propelling market growth in this region comprise the creation of 3D printed pills, which are custom made as per an individual’s age and weight, presence of well-established healthcare infrastructure, burgeoning demand for organs, and huge investments in the research and development activities.

In the Asia Pacific region, the global 3D bioprinting market will grow at a quick pace. It is likely to grow at a 27.25% CAGR and touch USD 507.18 million over the forecast period. Factors propelling market growth in this region comprise huge funds from the government to accelerate the pace of the 3D printing technology, developments and innovations in the healthcare sector, and plentiful opportunities.

In Europe, the global 3D bioprinting market will have a remarkable growth during the forecast period and is likely to touch USD 649.91 million by the end of 2023. Factors propelling market growth in the region comprise agreements between industry players, rising cases of cosmetic surgery, and increasing emphasis on health & wellness.

In the MEA, the global 3D bioprinting market will have a slow growth during the forecast period.

Key Players

Notable players profiled in the 3D bioprinting market report include FUJIFILM Wako Automation Corporation (U.S.), Nano3D Biosciences Inc. (U.S.), Organovo Holdings Inc. (U.S.), REGENHU Ltd. (Switzerland), Aspect Biosystems Ltd. (Canada), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), EnvisionTEC GmbH (Germany), Stratasys Ltd. (U.S.), Cyfuse Biomedical K.K. (Japan), Poietis (France), and Cellink AB (Sweden).

Industry News

Feb 2020: UPM has recently launched bioinks, called GrowInk. It has been designed for different 3D bioprinting applications, including regenerative medicine and tissue engineering. Water and nano fibrillar cellulose are the two key components of this bioink. This is integrated for offering a defined matrix that can be mixed directly with cells as well as customized. It will be available in three variants- GrowInk-N, GrowInk-T, and GrowInk-ALG.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future®

99 Hudson Street,5Th Floor

New York, New York 10013

United States of America

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more